Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Gold Star Distribution is recalling Claritin over CGMP deviations, citing insanitary conditions including rodent exposure and activity at its distribution center.
Alvogen is recalling a lot of Levothyroxine Sodium Tablets, 150mcg, after a pharmacy reported a single bottle containing 88 mcg tablets instead of 150 mcg tablets.
Gold Star Distribution is recalling Liquid NyQuil over CGMP deviations, citing insanitary conditions including rodent exposure and activity at its distribution center.
Sun Pharmaceutical Industries is recalling 24,624 bottles of Fluocinolone Acetonide Topical Solution 0.01% after an out of specification result for a known impurity.
Encon Safety Products is recalling 7,677 bags of AQ 120 GFEW Aquarion Preserved Cartridges over cGMP deviations.
Sun Pharmaceutical Industries is recalling Clindamycin Phosphate Topical Solution 1% after out of specification results for total impurities and for assay.
About 25,000 Ruahouine Hair Growth Serum bottles are being recalled because the serum contains minoxidil and the packaging is not child-resistant.
About 16,900 RootStim Beard Growth Serum bottles are being recalled because the serum contains minoxidil and the packaging is not child-resistant.
MediNatura is recalling all lots within expiry of ClearLife Allergy Nasal Spray, Extra Strength, after the products were found to contain yeast, mold and Achromobacter.
MediNatura is recalling all lots within expiry of ReBoost Nasal Spray after the products were found to contain yeast, mold and microbial contamination identified as Achromobacter.
Imprimis NJOF is recalling 778 boxes containing 15,540 pre-filled syringes of Dexamethasone and Moxifloxacin intraocular injection over glass-like particles.
Imprimis NJOF is recalling 596 boxes containing 11,920 pre-filled syringes of Dexamethasone, Moxifloxacin and Ketorolac intraocular injection over glass-like particles.
Imprimis NJOF is recalling 314 boxes containing 6,280 pre-filled syringes of Tri-Moxi triamcinolone and moxifloxacin intraocular injection over glass-like particles.
Alembic Pharmaceuticals is recalling Fesoterodine Fumarate Extended-release Tablets, 8 mg, because levels of a diester impurity exceeded the specification limit.
Signature Formulations is recalling 570 bottles of ORL Kids Mouthwash, bubblegum flavour, over current good manufacturing practice deviations.
SpecGx is recalling 74,544 bottles of Oxycodone and Acetaminophen CII Tablets, 7.5 mg/325 mg, because of the potential for the imprint to be missing on tablets.
AvKARE is recalling 7,991 cartons of Rosuvastatin Tablets, USP 10 mg, because the product was out of specification for dissolution.
Signature Formulations is recalling 1,458 containers of ORL Kids Natural Toothpaste, bubblegum flavour, over current good manufacturing practice deviations.
SpecGx is recalling 287,988 bottles of Oxycodone and Acetaminophen CII Tablets, 10 mg/325 mg, because of the potential for the imprint to be missing on tablets.
Novo Nordisk is recalling Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.
CareFusion 213 is recalling 106,400 units of BD ChloraPrep Triple Swabsticks over a lack of assurance of sterility.
Novo Nordisk is recalling Wegovy (semaglutide) Injection, 1 mg/0.5 mL prefilled pens, over the presence of particulate matter after hair was found in a prefilled syringe.
Glenmark Pharmaceuticals is recalling 96,948 packs of Ondansetron Orally Disintegrating Tablets, 4mg, because the blister packs are not fully sealed and tablets are falling out.
Zydus Pharmaceuticals is recalling 2,136 bottles of traZODONE Hydrochloride Tablets, 100mg, after a product complaint that some tablets had a dent on the plain side of the tablet surface.
Merck Sharp & Dohme is recalling 3 single-dose kits of Emend (aprepitant) for oral suspension over the potential presence of metal particulates in the product.